Sigyn Therapeutics, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Benjamin & Ko, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.25 USD | +5.00% |
|
-.--% | +10.99% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.99% | 6.61M | |
-6.24% | 180B | |
-6.39% | 98.89B | |
-5.97% | 66.26B | |
-9.61% | 44.61B | |
+8.84% | 44.02B | |
+10.13% | 40.12B | |
+12.69% | 29.19B | |
+13.33% | 23.41B | |
-7.83% | 23.64B |
- Stock Market
- Equities
- SIGY Stock
- News Sigyn Therapeutics, Inc.
- Sigyn Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt